Log In
BCIQ
Print this Print this
 

JP-11646

  Manage Alerts
Collapse Summary General Information
Company Jasco Pharmaceuticals LLC
DescriptionOral PIM2 (PIM2) inhibitor
Molecular Target Pim-2 (PIM2)
Mechanism of ActionPIM2 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple myeloma (MM)
Indication DetailsTreat multiple myeloma (MM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today